Urology & Nephrology Clinical Trials This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

Communicating About Choices in Transplantation
Condition: End Stage Renal Disease and Kidney TransplantationIntervention: Behavioral: COACH ProgramSponsors: Virginia Commonwealth University; Virginia Commonwealth University; Health Resources and Services Administration (HRSA)Not yet recruiting - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 7, 2013 Category: Research Source Type: clinical trials

Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1
Condition: Postmenopausal OsteoporosisIntervention: Drug: Liuwei Dihuang PillsSponsors: Fujian Institute Of Trational Chinese Medicine; Fujian Institute Of Trational Chinese MedicineRecruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2013 Category: Research Source Type: clinical trials

The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)
Condition: Non Alcoholic Fatty Liver DiseaseInterventions: Behavioral: Unsupervised exercise training; Behavioral: Supervised exercise trainingSponsors: University of Liverpool; University of Liverpool; Royal Liverpool University Hospital; University of Surrey; Imperial College London; Royal Surrey County HospitalActive, not recruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2013 Category: Research Source Type: clinical trials

The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)
Condition: Non Alcoholic Fatty Liver DiseaseInterventions: Behavioral: Unsupervised exercise training; Behavioral: Supervised exercise trainingSponsors: University of Liverpool; University of Liverpool; Royal Liverpool University Hospital; University of Surrey; Imperial College London; Royal Surrey County HospitalActive, not recruiting - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2013 Category: Research Source Type: clinical trials

RAS Quantification in Patients With Aliskiren or Candesartan
Conditions: Hypertension; Chronic Kidney Disease; ProteinuriaInterventions: Other: RAS blockade discontinuation; Drug: Aliskiren; Drug: CandesartanSponsors: Medical University of Vienna; Medical University of ViennaRecruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2013 Category: Research Source Type: clinical trials

Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension
Conditions: Hypertension; Chronic Kidney DiseaseIntervention: Procedure: Renal sympathetic denervationSponsors: UMC Utrecht; UMC Utrecht; ZonMw: The Netherlands Organisation for Health Research and Development; MedtronicNot yet recruiting - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2013 Category: Research Source Type: clinical trials

Tissue-Specific Metabolic Reprogramming in Diabetic Complications
Condition: Type 1 Diabetes MellitusInterventions: Procedure: Euglycemic clamp (normal blood sugar clamp) for 4 hours; Procedure: hyperglycemic clamp (elevated blood sugar to 300) for 4 hoursSponsors: University of Michigan; University of Michigan; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting - verified March 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2013 Category: Research Source Type: clinical trials

Dose-finding Study of MCI-196
Conditions: Chronic Kidney Disease; Dialysis; Hyperphosphatemia; PaediatricInterventions: Drug: colestilan-L; Drug: colestilan-M; Drug: colestilan-H; Drug: CBPBSponsors: Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma CorporationNot yet recruiting - verified March 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2013 Category: Research Source Type: clinical trials

Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure
Condition: Renal Transplant Patients After Return to DialysisInterventions: Procedure: Transplantectomy within two months after return to dialyse; Procedure: Progressive reduction of immunosuppression. Transplantectomy for cause onlySponsors: Hospices Civils de Lyon; Hospices Civils de LyonRecruiting - verified March 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2013 Category: Research Source Type: clinical trials

Data Demonstrating the Safety and Efficacy of Chimerix's Antiviral CMX001 Presented at BMT Tandem Meetings
- No evidence of CMX001-associated kidney toxicity was seen in stem cell transplant recipients who were enrolled in a 230-patient Phase 2 study to evaluate CMX001 for prevention of cytomegalovirus (CMV) infection. Subjects on CMX001 had stable to... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 25, 2013 Category: Pharmaceuticals Source Type: clinical trials

Role of FGF-23 as a Prognosis Biomarker in Intensive Care Patients
Conditions: Sepsis; Acute Kidney InjuryIntervention: Sponsors: University of Chile; University of ChileRecruiting - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 25, 2013 Category: Research Source Type: clinical trials

HemoShear to Present Translational Findings from its Vascular and Liver Human Relevant Systems
CHARLOTTESVILLE, Va., Feb. 21, 2013 /PRNewswire/ -- HemoShear LLC, a biotechnology research company and leading developer of human and animal cell-based systems for discovery and assessment of new drug compounds, will present three... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 21, 2013 Category: Pharmaceuticals Source Type: clinical trials

AVEO and Astellas Report Final Overall Survival Results from TIVO-1
Median Overall Survival of 28.8 Months Reported for Tivozanib in Patients with Advanced Kidney Cancer CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Feb 12, 2013 - AVEO Oncology (NASDAQ:AVEO) and Astellas Pharma Inc. (TSE:4503) today announced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 13, 2013 Category: Pharmaceuticals Source Type: clinical trials

Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease.
Conditions: Alcoholism; Liver Disease; Liver FibrosisIntervention: Other: liver biopsieSponsors: Rennes University Hospital; Rennes University HospitalRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2013 Category: Research Source Type: clinical trials